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introduction: Left atrial appendage (LAA) isolation is known to be an important adjunctive therapy to improve outcomes of pulmonary vein 
isolation in patients with persistent AF. Percutaneous endo-epicardial LAA closure system (LARIAT) can result in both mechanical and electrical 
exclusion of the LAA and may potentially aid in improving the outcomes of ablation in persistent AF by eradicating the LAA triggers. We intended to 
evaluate the additional benefit of concomitant LARIAT procedure when added to conventional AF ablation.
methods: In this prospective observational study, forty consecutive patients who underwent LARIAT procedure followed by AF ablation (group-I) 
were enrolled. Age, gender and type of AF matched patients undergoing only AF ablation served as the control (group-II). Recurrence of AF was 
measured during 1 year of follow up.
results: The mean age of the population was 70 years with 24 (30%) females. Baseline characteristics including age, body mass index, left 
ventricular ejection fraction were similar in both the groups. Left atrial size was higher in the LARIAT group (5.1 vs 4.6; cm p=0.006). CHADS2 and 
CHA2DS2-Vasc scores were higher in the LARIAT group. The primary outcome of AF recurrence was lower in the LARIAT group (34% vs 55%, p=0.025) 
after the first ablation. Also, fewer patients in the LARIAT group needed repeat ablation (15% vs 35%, p=0.04).
conclusions:  LAA ligation with the LARIAT device appears to incrementally benefit in decreasing the recurrence of AF after AF ablation.
